Interferon-γ is essential for destruction of β cells and development of insulin-dependent diabetes mellitus

Journal of Experimental Medicine

Volumn 185, Issue 3, 1997, Pages 531-539

  Von Herrath, Matthias G ^a   Oldstone, Michael B A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INSULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PERFORIN; VIRUS GLYCOPROTEIN; VIRUS NUCLEOPROTEIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNITY; CELL DESTRUCTION; CELL KILLING; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EMBRYO; ETIOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; DIABETES MELLITUS, TYPE 1; IMMUNOHISTOCHEMISTRY; INSULIN; INTERFERON TYPE II; ISLETS OF LANGERHANS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; PROMOTER REGIONS (GENETICS); RATS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0031051747     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.3.531     Document Type: Article

References (51)

1. Baekkeskov, S., and B. Hansen. 1990. Human diabetes. Curr. Top. Microbiol. Immunol. 164:1-198.
2. Gamble, D.R. 1980. The epidemiology of insulin-dependent diabetes with particular reference to the relationship of virus infection to its etiology. Epidemiol. Rev. 2:49-70.
3. Bach, J.F. 1994. IDDM as an autoimmune disease. Endocr. Rev. 15:516-532.
4. Tisch, R., X.-D. Yang, S.M. Singer, R.S. Liblau, L. Fugger, and H.O. McDevitt. 1993. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature (Lond.). 366:72-75.
5. Shehadeh, N., F. La Rosa, and K. Lafferty. 1993. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J. Autoimmun. 6:291-300.
6. Oldstone, M.B.A., M. Nerenberg, V. Southern, J. Price, and H. Lewicki. 1991. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of the anti-self (virus) immune response. Cell. 65:319-331.
7. Allison, J., L. Malcolm, N. Chosich, and J.F.A.P. Miller. 1992. Inflammation but not autoimmunity occurs in transgenic mice expressing constitutive levels of interleukin-2 in islet beta-cells. Enr.J. Immunol. 22:1115-1121.
8. Ohashi, P., S. Oehen, P. Aichele, H. Pircher, B. Odermatt, P. Herrera, Y. Higuchi, K. Buerki, H. Hengartner, and R.M. Zinkernagel. 1993. Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor alpha. J. Immunol. 150:5185-5194.
9. Campbell, I., T. Kay, L. Oxbrow, and L.C. Harrison. 1991. Essential role for interferon-gamma and interleukin-6 in autoimmune insulin dependent diabetes in NOD/Wehi mice. J. Clin. Invest. 87:739-742.
10. Campbell, I., and L.C. Harrison. 1990. Molecular pathology of type I diabetes. Mol. Biol. Med. 7:299-309.
11. Sarvetnick, N., J. Shizuru, D. Liggitt, L. Martin, B. McIntyre, A. Gregory, T. Parslow, and T. Stewart. 1990. Loss of pancreatic islet tolerance induced by β-cell expression of interferon-γ. Nature (Lond.). 346:844-847.
12. Lee, M.S., M.G. von Herrath, H. Reiser, M.B.A. Oldstone, and N. Sarvetnick. 1995. Sensitization to self (virus) antigen by in situ expression of murine interferon-γ. J. Clin. Invest. 95:486-92.
13. Lee, M-S., L. Wogensen, J. Shirzuru, M.B.A. Oldstone, and N. Sarvetnick. 1994. Pancreatic islet production of murine interleukin-10 does not inhibit immune-mediated tissue destruction. J. Clin. Invest. 93:1332-1338.
14. Nagata, M., K. Yokono, M. Hayakawa, Y. Kawase, N. Hatamon, W. Ogawa, K. Yonezawa, K. Shii, and S. Baba. 1989. Destruction of pancreatic islet cells by cytotoxic T lymphocytes in nonobese diabetic mice. J. Immunol. 143:1155-1162.
15. Fitch, F.W., M. McKisic, D. Lancki, and T. Gajewski. 1993. Differential regulation of murine T-lymphocyte subsets. Annu. Rev. Immunol. 11:29-48.
16. O'Garra, A., and M. Kenneth. 1994. Role of cytokines in determining T-lymphocyte function. Curr. Opin. Immunol. 6: 458-466.
17. Modlin, R., and T.B. Nutman. 1993. Type 2 cytokines and negative immune regulation in human infections. Curr. Opin. Immunol. 5:511-517.
18. Bogen, S., I. Fogelmann, and A. Abbas. 1993. Analysis of IL-2, IL-4, and IFN-γ producing cells in situ during immune responses to protein antigens. J. Immunol. 150:4197-4205.
19. Flynn, J.L., J. Chan, K. Riebold, D. Dalton, T. Stewart, and B. Bloom. 1993. An essential role for interferon-γ in resistance to mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2254.
20. Graham, M.B., D. Dalton, D. Giltinan, V. Braciale, T. Stewart, and T. Braciale. 1993. Response to influenza infection in mice with a targeted disruption of the interferon γ gene. J. Exp. Med. 178:1725-1732.
21. Tishon, T., H. Lewicki, G. Rall, M.G. von Herrath, and M.B.A. Oldstone. 1995. An essential role for type I interferon-γ in terminating persistent viral infection. Virology. 212:244-250.
22. Sarvetnick, N., D. Liggitt, S.L. Pitts, S.E. Hansen, and T.A. Stewart. 1988. Insulin-dependent diabetes mellitus induced in transgenic mice by ecotopic expression of class II MHC and interferon-gamma. Cell. 52:773-782.
23. Dalton, D., S. Pitts-Meek, S. Keshav, I. Figari, A. Bradley, and T. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science (Wash. DC). 259:1739-1743.
24. Hultgren, B., X. Huang, N. Dybdal, and T. Stewart. 1996. Genetic absence of γ-interferon delays but does not prevent diabetes in NOD mice. Diabetes. 45:812-817.
25. von Herrath, M.G., J. Dockter, H. Lewicki, and M.B.A. Oldstone. 1994. How virus induces a rapid and slow onset IDDM in a transgenic model. Immunity. 1:231-242.
26. von Herrath, M.G., S. Guerder, H. Lewicki, R. Flavell, and M.B.A. Oldstone. 1995. Coexpression of B7.1 and viral (self) transgenes in pancreatic β-cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes. Immunity. 3:727-738.
27. von Herrath, M.G., J. Dockter, M. Nerenberg, J. Gairin, and M.B.A. Oldstone. 1994. Selection and adaptability of CTL responses in tg mice expressing a viral protein in the thymus. J. Exp. Med. 180:1901-1910.
28. Wong, S., L. Wen, I. Visintin, R.A. Flavell, C. Janeway, Jr. 1996. CD8 cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset diabetes in NOD mice in the absence of CD4 cells. J. Exp. Med. 183:67-76.
29. Oldstone, M.B.A., P. Southern, M. Rodriguez, and P. Lampert. 1984. Virus persists in β-cells of islets of Langerhans and is associated with chemical manifestation of diabetes. Science (Wash. DC). 224:1440-1443.
30. Wegmann, D., R. Gill, M. Glaser, N. Schloot, and D. Daniel. 1994. Analysis of the spontaneous T-cell response to insulin in NOD mice. J. Autoimmun. 7:833-843.
31. Hayakawa, M., K. Yokono, M. Nagata, N. Hatamori, W. Ogawa, A. Miki, H. Mizoguit, and S. Baba. 1991. Morphological analysis of selective destruction of pancreatic β-cell by cytotoxic T lymphocytes in NOD mice. Diabetes. 40:1210-1217.
32. Kagi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science (Wash. DC). 265:528-530.
33. Podack, E.R., H. Hengartner, and M.G. Lichtenheld. 1991. A central role of perforin in cytolysis? Annu. Rev. Immunol. 9: 129-157.
34. Kagi, D., B. Odermatt, F. Ohashi, R.M. Zinkernagel, and H. Hengartner. 1996. Development of insulitis without diabetes in transgenic mice lacking perforin dependent cytotoxicity. J. Exp. Med. 183:2143-2149.
35. Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature (Lond.). 370:650-652.
36. Southern, P.J., M.K. Singh, Y. Riviere, D.R. Jacoby, M.J. Buchmeier, and M.B.A. Oldstone. 1987. Molecular characterization of the genome S RNA segment from lymphocytic choriomeningitis virus. Virology. 157:145-155.
37. Dutko, F.J., and M.B.A. Oldstone. 1983. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. J. Gen. Virol. 64:1689-1698.
38. Gairin, J.E., and M.B.A. Oldstone. 1993. Virus and cytotoxic T lymphocytes. 1. Crucial role of viral peptide secondary structure in MHC class I interactions. J. Virol. 67:2903-2907.
39. Whitton, J.L., P.J. Southern, and M.B.A. Oldstone. 1988. Analysis of the CTL responses to glycoprotein and nucleoprotein components of LCMV. Virology. 162:3211-3217.
40. Whitton, J.L., J.R. Gebhard, H. Lewicki, A. Tishon, and M.B.A. Oldstone. 1988. Molecular definition of a major cytotoxic T lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus. J. Virol. 62:687-695.
41. Whitton, J.L. 1990. Lymphocytic choriomeningitis virus CTL. Semin. Virol. 1:257-262.
42. k restricted CTL clones recognize internal viral gene products and cause CNS disease. J. Neuroimmunol. 41:15-20.
43. von Herrath, M.G., J. Allison, J.F.A.P. Miller, and M.B.A. Oldstone. 1995. Focal expression of interleukin-2 does not break unresponsiveness to "self" (viral) antigen expressed in β cells but enhances development of autoimmune disease (diabetes) after initiation of an anti-self immune response. J. Clin. Invest. 95:477-485.
44. Silver, L.M. 1995. Mouse Genetics. Oxford University Press, New York. 233-306.
45. Guidotti, L., T. Ishikawa, M. Hobbs, B. Matzke, R. Schreiber, and F.V. Chisari 1996. Intracellular inactivation of HBV by CTL. Immunity. 4:25-36.
46. Guidotti, L., P. Borrow, M. Hobbs, B. Matzke, I. Gresser, M.B.A. Oldstone, and F.V. Chisari. 1996. Viral cross talk: intracellular inactivation of the HBV during an unrelated viral infection of the liver. Proc. Natl. Acad. Sci. USA. 93:4589-4594.
47. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethman, R. Kamijo, J. Vilcek, R.M. Zinkernagel, and M. Aguet. 1993. Immune responses in mice that lack the γ-IFN receptor. Science (Wash. DC). 1742-1748.
48. Tough, D., P. Borrow, and J. Sprent. 1996. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science (Wash. DC). 272:1947-1950.
49. Walsh, C.M., M. Matloubian, C.C. Liu, R. Ueda, M.T. Kurahag, J.D. Young, R. Ahmed, and W.R. Clark. 1994. Immune function in mice lacking the perfogene. Proc. Natl. Acad. Sci. USA. 91:10854-10858.
50. Hanafusa, T., and S. Tarui. 1990. Immune pathogenesis of diabetes in the nonobese diabetic mouse: an overview. Curr. Top. Microbiol. Immunol. 156:15-25.
51. Krakowski, M., and T. Owens. 1996. Interferon-γ confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 26:1641-1646.